Skip to main content

Table 2 Prevalence of HPV, CIN and Cervical Cancer

From: Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Prevalence of hrHPV

8.4%

Pista et al. (2013) [26]

Prevalence of HPV16 and/or 18

2.4%

Pista et al. (2013) [26]

Prevalence of CIN1

1.4%

Wright et al. (2012) [27]

Prevalence of CIN2

0.4%

Wright et al. (2012) [27]

Prevalence of CIN3

0.6%

Wright et al. (2012) [27]

Prevalence of invasive cervical cancer

0.048%

Wright et al. (2012) [27]